We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$233M
AUM Growth
-$185M
Cap. Flow
-$212M
Cap. Flow %
-90.7%
Top 10 Hldgs %
36.18%
Holding
61
New
18
Increased
2
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12.1M
2
UHS icon
Universal Health Services
UHS
+$7.71M
3
ELV icon
Elevance Health
ELV
+$7.36M
4
ZBH icon
Zimmer Biomet
ZBH
+$5.73M
5
PFE icon
Pfizer
PFE
+$4.95M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$23.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10.3M
3
MDT icon
Medtronic
MDT
+$10M
4
SNN icon
Smith & Nephew
SNN
+$8.57M
5
CTLT
CATALENT, INC.
CTLT
+$8.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.2%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$130B
$4.37M 1.87%
+70,000
New +$4.11M
IQV icon
27
IQVIA
IQV
$39.8B
$4.23M 1.81%
15,000
-20,000
-57% -$5.19M
MOH icon
28
Molina Healthcare
MOH
$10.8B
$3.98M 1.7%
12,500
-7,500
-38% -$2.23M
OPCH icon
29
Option Care Health
OPCH
$3.57B
$3.7M 1.58%
130,000
-25,000
-16% -$656K
ISRG icon
30
Intuitive Surgical
ISRG
$142B
$3.67M 1.57%
+10,199
New +$3.51M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$13.6B
$3.53M 1.51%
40,000
-25,000
-38% -$2.06M
WST icon
32
West Pharmaceutical
WST
$24.8B
$3.52M 1.51%
+7,500
New +$3.23M
SYK icon
33
Stryker
SYK
$133B
$3.34M 1.43%
12,500
– –
CYH icon
34
Community Health Systems
CYH
$410M
$3.32M 1.42%
249,768
-65,232
-21% -$820K
CAH icon
35
Cardinal Health
CAH
$54.5B
$3.09M 1.32%
+60,000
New +$2.94M
HOLX
36
DELISTED
Hologic
HOLX
$3.06M 1.31%
40,000
-20,000
-33% -$1.47M
SEM
37
DELISTED
Select Medical
SEM
$2.65M 1.13%
167,040
-204,160
-55% -$3.48M
GH icon
38
Guardant Health
GH
$22.2B
$2.5M 1.07%
+25,000
New +$2.59M
NTRA icon
39
Natera
NTRA
$45.5B
$2.33M 1%
+25,000
New +$2.59M
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.94B
$2.25M 0.96%
+25,000
New +$2.14M
EHC icon
41
Encompass Health
EHC
$12.3B
$1.96M 0.84%
37,710
-87,990
-70% -$4.54M
EW icon
42
Edwards Lifesciences
EW
$53.6B
$1.95M 0.84%
+15,068
New +$1.76M
CRSP icon
43
CRISPR Therapeutics
CRSP
$5.22B
$1.9M 0.81%
+25,000
New +$2.18M
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.46M 0.62%
+9,918
New +$1.54M
BPMC
45
DELISTED
Blueprint Medicines
BPMC
$1.07M 0.46%
+10,000
New +$1.05M
ACHC icon
46
Acadia Healthcare
ACHC
$2.95B
– –
-18,893
Closed -$1.21M
BRKR icon
47
Bruker
BRKR
$9.03B
– –
-75,000
Closed -$5.86M
CNC icon
48
Centene
CNC
$33.1B
– –
-100,000
Closed -$6.23M
DGX icon
49
Quest Diagnostics
DGX
$26.2B
– –
-6,000
Closed -$3.63M
GRFS
50
Grifois
GRFS
$5.4B
– –
-200,000
Closed -$2.92M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q4 2021 Portfolio in Review

As of Q4 2021, Sivik Global Healthcare held 61 positions worth $233M, down 44% from $419M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare withdrew a net $212M in Q4 2021, closing 16 positions and reducing 24 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 69% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in State Street SPDR S&P Biotech ETF worth $11.2M.

  • Sivik Global Healthcare's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 100,000 shares worth $11.2M.
  • Sivik Global Healthcare added most to Humana in Q4 2021, an estimated $2.21M increase.
  • Sivik Global Healthcare's biggest Q4 2021 reduction was UnitedHealth, cutting an estimated $23.8M.
  • Sivik Global Healthcare fully exited Seagen Inc. Common Stock in Q4 2021, selling an estimated $10.3M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $233M portfolio in Q4 2021.
  • Sivik Global Healthcare opened 18 new positions and closed 16 in Q4 2021.
  • Sivik Global Healthcare's portfolio value fell 44% quarter-over-quarter to $233M.

Based on Sivik Global Healthcare's 13F filing for Q4 2021, filed 8 Feb 2022.